#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Urethral valves Mitochondrial encephalomyopathy Kawasaki's disease Mitochondrial myopathy Eosinophilic oesophagitis Cortical dysplasia Chorioretinitis Extra-osseous Ewing's sarcoma recurrent Neuroendocrine carcinoma Neurodermatitis Huntington's disease Dent's disease Mantle cell lymphoma Renal cancer metastatic Nephrotic syndrome More trials…

    Learn about Rare Diseases

    Glycogen storage disease type I – Trials in Disease Glycogen storage disease type I – Treatment Gaucher’s disease type III – Diagnostics Haemophilia – Treatment Mantle cell lymphoma stage III – Trials in Disease Chondrosarcoma metastatic – Life with Disease Inclusion body myositis Medulloblastoma recurrent – Life with Disease Hairy cell leukaemia recurrent Rosai-Dorfman syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Antiemetics And Antinauseants Imidapril Hydrochloride Metolazone MEGESTROL ACETATE Baricitinib Hydroxi-Methionine Calcium Mrna-3210 Salbutamol Sulfate IMA401 GRISNILIMAB SETARITOX CHONDROITIN SULFATE SODIUM Gsk3739937 Oxymetazoline Hydrochloride Furosemide Ph. Eur. Repotrectinib Bempikibart Milademetan Avibactam Enfuvirtide Tepotinib More therapies…

    Learn about Your Condition

    Breast proliferative changes Naevus flammeus Ewing's sarcoma recurrent Cardiac ventricular thrombosis Adrenoleukodystrophy Prinzmetal angina Rheumatoid arthritis Nodal osteoarthritis Ovarian epithelial cancer Anal squamous cell carcinoma Arrhythmia Chronic coronary syndrome Pneumonia chlamydial Actinic keratosis Hepatic cirrhosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Efficacy and Safety of LY4005130 Compared with Placebo in Adults with Non‑Segmental Vitiligo

    Recruiting

    2 1
    Investigated Diseases:
    • Vitiligo
    Belgium Poland

  • Safety and Antitumor Activity of PF-08634404 Alone or with Enfortumab Vedotin in Adults with Locally Advanced or Metastatic Urothelial Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma metastatic
    Investigated Drugs:
    • Enfortumab Vedotin
    The Netherlands Spain

  • Metronidazole, Bismuth Oxide and Tetracycline Hydrochloride Fixed‑Dose Combination vs Standard First‑line Therapy for Adults with Helicobacter pylori Infection

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Clarithromycin
    • Esomeprazole
    • Tetracycline Hydrochloride
    Greece

  • Study of TYRA-300 in Adults with Low Grade Upper Tract Urothelial Carcinoma to Assess Efficacy and Safety

    Recruiting

    2 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • Tyra-300-B01
    Bulgaria France Spain

  • Long‑Term Safety and Efficacy of RO7790121 in Adults with Moderate to Severe Rheumatoid Arthritis: Extension Study

    Recruiting

    2 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Ro7790121
    Belgium Denmark France Germany Italy Poland +1

  • Study of GSK5764227 Safety and Efficacy in Adults with Previously Treated Advanced Unresectable or Metastatic Sarcoma

    Recruiting

    1 1 1
    Investigated Diseases:
    • Sarcoma
    Investigated Drugs:
    • GSK5764227
    France
Previous Page
1 … 8 9 10 11 12 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!